HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 57.00
-0.20 (-0.35%)
Jun 18, 2026, 2:55 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.62 billion as of June 18, 2026. Its market cap has decreased by -19.72% in one year.
Market Cap
2.62B
Enterprise Value
2.15B
Revenue
293.23M
Ranking
n/a
PE Ratio
23.46
Stock Price
57.00
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.62B, a decrease of -36.95%. That is a compound annual growth rate of -15.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.62B | -9.52% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Energenesis Biomedical CO.,LTD. | 3.22B |
| Shine-On BioMedical | 3.15B |
| BioGend Therapeutics | 3.10B |
| BRIM Biotechnology | 2.98B |
| Apex Biotechnology | 2.93B |
| Genovate Biotechnology | 2.92B |
| GlycoNex Incorporation | 2.85B |
| Intech Biopharm | 2.74B |